Projected economic impact of clinical findings of generic entry of topiramate on G4 European countries.
about
Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EUCost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States.Generic substitution of antiepileptic drugs.Switching from brand-name to generic psychotropic medications: a literature review.Efficacy and safety of innovator versus generic drugs in patients with epilepsy: a systematic review.A Patient's Voice.
P2860
Projected economic impact of clinical findings of generic entry of topiramate on G4 European countries.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Projected economic impact of c ...... mate on G4 European countries.
@en
Projected economic impact of c ...... mate on G4 European countries.
@nl
type
label
Projected economic impact of c ...... mate on G4 European countries.
@en
Projected economic impact of c ...... mate on G4 European countries.
@nl
prefLabel
Projected economic impact of c ...... mate on G4 European countries.
@en
Projected economic impact of c ...... mate on G4 European countries.
@nl
P2093
P1476
Projected economic impact of c ...... mate on G4 European countries.
@en
P2093
Dominick Latrémouille-Viau
Maren Gaudig
Marie-Hélène Lafeuille
Mei Sheng Duh
Natalia Mishagina
Patrick Lefebvre
Pierre Emmanuel Paradis
Yuliya Moore
P304
P356
10.1185/03007990903044374
P407
P577
2009-07-01T00:00:00Z